Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,806 | 30,634 | 35,704 | 40,345 | 46,778 |
| TOTAL | $25,285 | $31,395 | $36,572 | $41,393 | $47,125 |
| Non-Current Assets | |||||
| PPE Net | 365 | 331 | 345 | 254 | 287 |
| Other Non-Current Assets | 242 | 265 | 286 | 307 | 326 |
| TOTAL | $607 | $596 | $630 | $561 | $613 |
| Total Assets | $25,892 | $31,990 | $37,202 | $41,953 | $47,738 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,462 | 4,512 | 3,855 | 3,035 | 3,391 |
| TOTAL | $5,606 | $4,651 | $3,990 | $3,166 | $3,519 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 92 | 130 | 166 | 202 | 236 |
| TOTAL | $92 | $130 | $166 | $202 | $236 |
| Total Liabilities | $5,698 | $4,781 | $4,157 | $3,368 | $3,755 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 203 | 203 | 203 | 203 | 203 |
| Common Shares | 0 | 1 | 0 | 1 | 1 |
| Retained earnings | -164,473 | -157,038 | -150,898 | -144,980 | -139,161 |
| Other shareholders' equity | 0 | 0 | 1,382 | 1,382 | 8,638 |
| TOTAL | $20,194 | $27,209 | $33,045 | $38,585 | $43,983 |
| Total Liabilities And Equity | $25,892 | $31,990 | $37,202 | $41,953 | $47,738 |